尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the detailed record of transactions filed by Flowers Kirsten, Directeur Commercial. Insider active across 2 companies, notably Kura Oncology, Inc.. Cumulatively, 4 reports have been published. Breakdown: 1 buy · 1 sell. Total volume traded: €24k. Activity tracked since 26 January 2022. The latest transaction was filed on 27 January 2023 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Kirsten Flowers is the Chief Commercial Officer at Kura Oncology, Inc. In this role, she oversees business operations and is responsible for the company's business development strategy. Flowers plays a key role in developing and implementing strategies that strengthen Kura Oncology's position in the market. Her expertise in business development is essential to support the company's growth.